Michael Gilman
CIK 1291144 · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.74M
Companies
2
Total Filings
19
Lifetime Open-Market Net
-$733.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Director | 62,055 | $44.18 | $2.74M | -$733.1K | 16 | 2026-06-08 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 2 | 2008-05-21 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-17 | SRRK | Sell (S) | −4,696 | -$308.0K | EDGAR |
| 2021-02-11 | SRRK | Sell (S) | −1,804 | -$117.4K | EDGAR |
| 2021-01-28 | SRRK | Mixed | — | -$187.3K | EDGAR |
| 2020-06-18 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2019-05-23 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2018-06-26 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2009-06-18 | — | Grant (A) | — | $0 | |
| 2008-05-21 | EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-29 | EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.